Probiotic and prebiotic treatments diminished the production of TSLP, cyst-LTs, LTC4, LTB4, GTP, and GOT which lead to control of inflammation in airways and harnessing of immune-inflammatory responses in lung and could control bronchial inflammo-pathology. The gene discussed is TSLP; the disease is cyst.